Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-18-005786
Filing Date
2018-05-09
Accepted
2018-05-09 18:18:17
Documents
1
Period of Report
2018-03-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f4032618rimon_wizepharma.html 4  
1 OWNERSHIP DOCUMENT f4032618rimon_wizepharma.xml 4 7627
  Complete submission text file 0001213900-18-005786.txt   9323
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047
Business Address RAVEN RAVID & CO. 32A HABARZEL ST. TEL AVIV L3 6971047 972-3-7676999
Rimon Gold Assets Ltd (Reporting) CIK: 0001721808 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52545 | Film No.: 18819874